Correlation Between Stoke Therapeutics and Zentalis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Stoke Therapeutics and Zentalis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Stoke Therapeutics and Zentalis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Stoke Therapeutics and Zentalis Pharmaceuticals Llc, you can compare the effects of market volatilities on Stoke Therapeutics and Zentalis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Stoke Therapeutics with a short position of Zentalis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Stoke Therapeutics and Zentalis Pharmaceuticals.
Diversification Opportunities for Stoke Therapeutics and Zentalis Pharmaceuticals
0.76 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Stoke and Zentalis is 0.76. Overlapping area represents the amount of risk that can be diversified away by holding Stoke Therapeutics and Zentalis Pharmaceuticals Llc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zentalis Pharmaceuticals and Stoke Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Stoke Therapeutics are associated (or correlated) with Zentalis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zentalis Pharmaceuticals has no effect on the direction of Stoke Therapeutics i.e., Stoke Therapeutics and Zentalis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Stoke Therapeutics and Zentalis Pharmaceuticals
Given the investment horizon of 90 days Stoke Therapeutics is expected to generate 1.02 times more return on investment than Zentalis Pharmaceuticals. However, Stoke Therapeutics is 1.02 times more volatile than Zentalis Pharmaceuticals Llc. It trades about 0.09 of its potential returns per unit of risk. Zentalis Pharmaceuticals Llc is currently generating about -0.08 per unit of risk. If you would invest 434.00 in Stoke Therapeutics on November 3, 2024 and sell it today you would earn a total of 714.00 from holding Stoke Therapeutics or generate 164.52% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.6% |
| Values | Daily Returns |
Stoke Therapeutics vs. Zentalis Pharmaceuticals Llc
Performance |
| Timeline |
| Stoke Therapeutics |
| Zentalis Pharmaceuticals |
Stoke Therapeutics and Zentalis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Stoke Therapeutics and Zentalis Pharmaceuticals
The main advantage of trading using opposite Stoke Therapeutics and Zentalis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Stoke Therapeutics position performs unexpectedly, Zentalis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zentalis Pharmaceuticals will offset losses from the drop in Zentalis Pharmaceuticals' long position.| Stoke Therapeutics vs. Adaptimmune Therapeutics Plc | Stoke Therapeutics vs. Black Diamond Therapeutics | Stoke Therapeutics vs. Relay Therapeutics | Stoke Therapeutics vs. Pliant Therapeutics |
| Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |